Literature DB >> 20699173

Hyperinsulinemic laminitis.

Melody A de Laat1, Catherine M McGowan, Martin N Sillence, Christopher C Pollitt.   

Abstract

Laminitis occurring in association with hyperinsulinemia is frequently encountered in today's equine population. New evidence suggests that hyperinsulinemia is the direct cause of this form of laminitis, rather than insulin resistance per se. The mechanism by which elevated serum insulin concentrations result in lamellar dysfunction is currently under investigation by many researchers and the use of a new insulin infusion model for investigating the pathogenesis of insulin-associated laminitis will doubtless enhance progress in this field of research. By focusing on the metabolic and vascular actions of insulin in the lamellar microenvironment, our research group is trying to gain an insight into the pathophysiological processes involved in this complex problem, in order to better understand the disease. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20699173     DOI: 10.1016/j.cveq.2010.04.003

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  3 in total

1.  Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis.

Authors:  Eleanor M Kellon; Kathleen M Gustafson
Journal:  Open Vet J       Date:  2022-08-07

2.  Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart.

Authors:  Melody A de Laat; Kaylynn J Gruntmeir; Christopher C Pollitt; Catherine M McGowan; Martin N Sillence; Véronique A Lacombe
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-22       Impact factor: 5.555

Review 3.  Obesity-Related Metabolic Dysfunction in Dairy Cows and Horses: Comparison to Human Metabolic Syndrome.

Authors:  Zsofia Daradics; Cristian M Crecan; Mirela A Rus; Iancu A Morar; Mircea V Mircean; Adriana Florinela Cătoi; Andra Diana Cecan; Cornel Cătoi
Journal:  Life (Basel)       Date:  2021-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.